Progression of hidradenitis suppurativa: Outcomes of placebo-treated patients in a phase 3, randomized, placebo-controlled trial (PIONEER II) - 21/04/16
Alexander Boer Kimball, Massachusetts General Hospital, Boston, MA, United States; Gregor B. E. Jemec, Roskilde Hospital, University of Copenhagen, Copenhagen, Denmark; David M. Brooks, AbbVie Inc, North Chicago, IL, United States; Yihua Gu, AbbVie Inc, North Chicago, IL, United States; Henrique D. Teixeira, AbbVie Inc, North Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. AbbVie Inc participated in the study design; study research; collection, analysis and interpretation of data; and writing, reviewing and approving of this publication. All authors had access to the data, and participated in the development and review. |
Vol 74 - N° 5S1
P. AB68 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?